Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("CITTERIO, F")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 83

  • Page / 4
Export

Selection :

  • and

STATO IMMUNOLOGICO IN PAZIENTI CON NEOPLASIE SOLIDE = ETAT IMMUNOLOGIQUE CHEZ DES MALADES ATTEINTS DE NEOPLASIES SOLIDESCITTERIO F; LUCIANI G; POZZETTO U et al.1980; MINERVA CHIR.; ITA; DA. 1980; VOL. 35; NO 10; PP. 717-722; BIBL. 26 REF.Article

Cardiac risk stratification of patients undergoing vascular surgeryROSSI, E; CITTERIO, F.Comprehensive therapy. 1999, Vol 25, Num 11-12, pp 461-466, issn 0098-8243Article

Cyclosporine's dual mechanism of action in inhibiting generation of the cytoplasmic activation signal and the nuclear response theretoCITTERIO, F; KAHAN, B. D.Transplantation. 1991, Vol 51, Num 6, pp 1248-1257, issn 0041-1337, 10 p.Article

The inhibitory effect of cyclosporine on the nuclear proliferative response to a variety of T cell activatorsCITTERIO, F; KAHAN, B. D.Transplantation. 1989, Vol 47, Num 2, pp 334-338, issn 0041-1337, 5 p.Conference Paper

Meeting the Early and Late Challenges of Renal Transplantation - Designing de novo Strategies for Improved OutcomesDAL CANTON, A; CITTERIO, F.Transplantation proceedings. 2008, Vol 40, Num 10, issn 0041-1345, 64 p., SUPConference Proceedings

Evolution of the therapeutic drug monitoring of cyclosporineCITTERIO, F.Transplantation proceedings. 2004, Vol 36, Num 2S, pp 420-425, issn 0041-1345, 6 p., SUPArticle

MTOR-What Does It Do?HALL, M. N.Transplantation proceedings. 2008, Vol 40, Num 10, issn 0041-1345, S5-S8, SUPConference Paper

Addressing the Challenges for Improving Long-Term Outcomes in Renal TransplantationCHAPMAN, J.Transplantation proceedings. 2008, Vol 40, Num 10, issn 0041-1345, S2-S4, SUPConference Paper

Optimizing Early De Novo Immunosuppression With SirolimusWEIR, M. R.Transplantation proceedings. 2008, Vol 40, Num 10, issn 0041-1345, S29-S31, SUPConference Paper

Stratifying Risk and Targeting Immunosuppressive StrategiesRUSS, G.Transplantation proceedings. 2008, Vol 40, Num 10, issn 0041-1345, S60-S62, SUPConference Paper

Neclear effects of cyclosporineCITTERIO, F; CHIOCCA, A. E; KAHAN, B. D et al.Transplantation proceedings. 1990, Vol 22, Num 4, pp 1742-1743, issn 0041-1345, 2 p.Conference Paper

New Approaches to De Novo Immunosuppression and Steroid EliminationLEBRANCHU, Y.Transplantation proceedings. 2008, Vol 40, Num 10, issn 0041-1345, S57-S59, SUPConference Paper

Reviewing the Evidence for De Novo Immunosuppression With SirolimusFLECHNER, S. M.Transplantation proceedings. 2008, Vol 40, Num 10, issn 0041-1345, S25-S28, SUPConference Paper

Preoperative Psychological Factors Predicting Graft Rejection in Patients Undergoing Kidney Transplant: A Pilot StudyCALIA, R; LAI, C; ACETO, P et al.Transplantation proceedings. 2011, Vol 43, Num 4, pp 1006-1009, issn 0041-1345, 4 p.Conference Paper

Significant Improvement in Patient Survival After Renal Transplantation in the Last DecadeFAVI, E; SALERNO, M. P; ROMAGNOLI, J et al.Transplantation proceedings. 2011, Vol 43, Num 1, pp 285-287, issn 0041-1345, 3 p.Conference Paper

Pharmacokinetics for Once- Versus Twice-Daily Tacrolimus Formulations in De Novo Kidney Transplantation: A Randomized, Open-Label TrialWLODARCZYK, Z; SQUIFFLET, J.-P; PIETRUCK, F et al.American journal of transplantation (Print). 2009, Vol 9, Num 11, pp 2505-2513, issn 1600-6135, 9 p.Article

Long-Term Clinical Impact of Vesicoureteral Reflux in Kidney TransplantationFAVI, E; SPAGNOLETTI, G; VALENTINI, A. L et al.Transplantation proceedings. 2009, Vol 41, Num 4, pp 1218-1220, issn 0041-1345, 3 p.Conference Paper

Higher incidence of acute rejection in renal transplant recipients with low everolimus exposureROMAGNOLI, J; CITTERIO, F; FAVI, E et al.Transplantation proceedings. 2007, Vol 39, Num 6, pp 1823-1826, issn 0041-1345, 4 p.Conference Paper

Azithromycin treatment of gingival hyperplasia in kidney transplant recipients is effective and safeCITTERIO, F; DI PINTO, A; BORZI, M. T et al.Transplantation proceedings. 2001, Vol 33, Num 3, pp 2134-2135, issn 0041-1345Conference Paper

Human humoral immune reactions against pig antigens : a method to clear preexisting preformed natural antibodiesPOZZETTO, U; CITTERIO, F; MAGGIANO, N et al.Transplantation proceedings. 1993, Vol 25, Num 1, issn 0041-1345, p. 450, 1Conference Paper

Fifteen Years of Clinical Studies and Clinical Practice in Renal Transplantation : Reviewing Outcomes With De Novo Use of Sirolimus in Combination With CyclosporineKAHAN, B. D.Transplantation proceedings. 2008, Vol 40, Num 10, issn 0041-1345, S17-S20, SUPConference Paper

Modern Approaches to Combining Sirolimus With Calcineurin InhibitorsSTEVENS, R. B.Transplantation proceedings. 2008, Vol 40, Num 10, issn 0041-1345, S21-S24, SUPConference Paper

Reducing the Risk of Viral Infection in Renal TransplantationTIBBLES, L. A.Transplantation proceedings. 2008, Vol 40, Num 10, issn 0041-1345, S48-S51, SUPConference Paper

Steroid Elimination-Who, When, How?MATAS, A. J.Transplantation proceedings. 2008, Vol 40, Num 10, issn 0041-1345, S52-S56, SUPConference Paper

The Impact of mTOR Inhibitors on the Development of MalignancyGEISSLER, E. K.Transplantation proceedings. 2008, Vol 40, Num 10, issn 0041-1345, S32-S35, SUPConference Paper

  • Page / 4